Nomograms for Predicting Survival of Patients With Newly Diagnosed Glioblastoma: Prognostic Factor Analysis of EORTC and NCIC Trial 26981-22981/Ce.3

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(07)70384-4

Related search